caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1639110307

Stanley ChangM.D.

OphthalmologyNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Stanley Chang's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 9 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
THE NEW YORK AND PRESBYTERIAN HOSPITAL73189
Laurence Mark
Anesthesiology · New York, NY
43118
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
3355
Leejee Suh
Ophthalmology · New York, NY
2371
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
1933
Sunrise Medical Laboratories, Inc.
Clinical Laboratory · Hicksville, NY
1738
WHITE PLAINS HOSPITAL MEDICAL CENTER1428
Northwell Health Laboratories
Clinical Laboratory · New Hyde Park, NY
1436
Ameripath New York Llc
Clinical Laboratory · White Plains, NY
1215
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,142
Unique beneficiaries
—
Total services
9,216
Distinct HCPCS
9
Medicare payment
$434K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,438 Ophthalmology providers in NY — top quintile (cohort median 1,869).
PRESCRIBING · PART D · 2024
Total Rx claims
454
Beneficiaries
—
Total drug cost
$44K
Distinct drugs
12
Brand share
37.9%
Top prescribed drugs
Latanoprost103 claims
Timolol Maleate88 claims
Prednisolone Acetate62 claims
Dorzolamide Hcl/Timolol Maleat56 claims
Erythromycin Base29 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$30
Payment records
1
By payment type
Food and Beverage$30
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
85.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
APM Entity